We provide a stepwise approach for the clinical pharmacy practitioner in the physician clinic or community pharmacy setting to secure compensation for cognitive services. How to establish compensation for pharmacist services is explored, including evaluating the payer mix, developing a relationship with the first-or third-party payer, becoming credentialed with a third-party payer, and creating a fee structure. We detail the physical process of billing, which involves completing appropriate billing forms, appropriately using billing codes, documenting cognitive services in the patient record, and obtaining the proper waivers and/or approvals to provide specific services such as laboratory services and immunizations. This comprehensive review of compensation for cognitive services available in the community pharmacy and physician office environment is designed to be a template for pharmacists to further develop specific strategies, implement fee structures, and obtain compensation in their pharmacy environment and payer mix. Exploration into these innovative markets will enable pharmacists to increase revenue as they enhance and expand their cognitive services for patients.
In the past decade, pharmacists have made significant advances in the development and implementation of pharmaceutical care or cognitive services. These innovative and effective patient care activities have improved health care in a variety of clinical areas, including immunizations, dyslipidemia, diabetes, asthma, and obesity. [1] [2] [3] [4] [5] [6] However, it is not financially feasible for pharmacists to perform these services at no cost when a considerable amount of time and resources are needed. When pharmacists provide pharmaceutical care, one of the challenging and critical components of this care is obtaining compensation for cognitive services. Although the terms compensation and reimbursement often are used interchangeably, each has a different meaning. Reimbursement reflects payment for an item at little or no profit; compensation refers to purchase of an item or service with additional payment for some value that has been added to that item or service. 7 When cognitive services are provided by pharmacists, value may be added to a drug or device. For example, diabetes education may be provided with the purchase of a blood glucose meter. Value also may be added to a patient' s care without the purchase of a drug or device. Smoking cessation and weight loss programs are PHARMACIST COMPENSATION FOR COGNITIVE SERVICES Snella et al excellent examples of how pharmacists can provide cognitive services in the clinic or community settings. Therefore, compensation, not reimbursement, is desired for the provision of pharmaceutical care.
Fortunately, political strides have been taken to help pharmacists receive compensation for their services. Not only are pharmacy organizations lobbying for this issue in the United States Congress, but also the Medicare Payment Advisory Commission has provided a statement of need for pharmacist compensation to members of Congress who make decisions about the Medicare program. This document, "Medicare Coverage of Nonphysician Practitioners," recommends that the Secretary assess models for collaborative drug therapy management services. 8 It promotes the benefits of drug therapy management and the need for pharmacist compensation, especially in outpatient settings. Political advances such as this are necessary for the progression of compensation nationally, but individual pharmacists must have the right tools and be adequately prepared to secure compensation for their services.
Development and implementation of compensation strategies are dependent on the pharmacy setting and individual state laws. Potential issues to consider for successfully obtaining compensation include physical location, demand for services, insurance carriers and regulations, and the ability to gain provider status. We present a stepwise approach for pharmacists to use in securing comprehensive compensation for activities provided in an outpatient physician office and/or a community setting. These activities include cognitive services, laboratory monitoring, procedures, and immunizations. These activities are dependent on factors such as state-specific collaborative practice agreements and statespecific pharmacist scope of practices, as well as external forces such as the national regulations regarding which professionals can be compensated for Medicare clients. Another external entity that has commented on the expanding scope of pharmacists is the American College of Physicians-American Society of Internal Medicine. 9 Although this group supports collaborative practice limited to inpatient care and patient education, the group does support compensation for pharmacists and the role of pharmacists as immunizers. Multiple pharmacist responses to this position statement have been published. [10] [11] [12] [13] [14] In addition to under-standing the factors that influence compensation, the various terms used when discussing compensation must be understood. A list of these terms with definitions is provided in Appendix 1.
15-19

Steps Involved in Establishing Compensation for Services
The specific strategy for compensation will vary with the type of service offered. Examples of cognitive services include patient education, anticoagulation monitoring, asthma management services, and cardiovascular risk reduction services. In addition to the cognitive component, laboratory tests such as hemoglobin A 1c performed with point-of-service testing devices may generate revenue. In a similar fashion, certain procedures may be performed during the patient visit and can be an additional resource. One example of this is the use of the heel ultrasonography to measure bone mineral density. Immunizations also may be a source of compensation and can include compensation for both the vaccine product and administration.
One of the first steps involved in investigating compensation options involves assessing the institution' s insurance payer mix. For example, a clinic with a large elderly patient component may service a primarily Medicare population. In contrast, in an institution with a large pediatric population, Medicaid may be the most common insurance carrier. In most instances, there will be a variety of insurance carriers for a clinic or pharmacy. When evaluating the insurance carriers, it is important to note the insurance carrier for the medical benefits of the insurance instead of the insurance carrier that is billed for the pharmacy benefits. For example, a patient may have Medicare as their primary insurance that covers medical and laboratory fees but may have limited prescription coverage. Compensation strategies discussed in this article will focus on billing the insurance carrier' s medical benefits for services. Billing for the pharmacy benefit portion and durable medical equipment will not be addressed.
Relationship Between Pharmacist and Insurance Carrier
A great deal of variation exists in the relationships between the pharmacist and the different types of insurance carriers, including Medicare, Medicaid, third-party payers, and managed care organizations (MCOs; Table 1 ). The Centers for Medicare and Medicaid Services (CMS), which administers Medicare and Medicaid payments for services, and the federal government are usually less flexible in dealing with nonphysician providers than are private insurers who are not as restrained by federal regulations. Private third-party payers may or may not choose to accept pharmacists as providers for purposes of compensation for cognitive services. There are some instances in which private insurance carriers have a payer relationship for cognitive services with pharmacists or pharmacies. Managed care organizations, such as health maintenance organizations (HMOs), may contract with pharmacists or pharmacies to provide cognitive services. There are successful examples from around the country in which pharmacists have relationships with MCOs for cognitive services, such as disease management programs. 7 
Medicare
As noted earlier, CMS is mandated to pay only those providers who are recognized in law. The guiding legislation is Title XVIII of the Social Security Act. 20 There are two parts of this Act that describe coverage: Part A or inpatient coverage and Part B or outpatient coverage. It is clear in these regulations that pharmacists are not recognized as providers within the Act and therefore are not eligible for reimbursement or compensation for cognitive services as are physicians and other named providers (section 1861-s). 20 There are two exceptions. The first exception is that pharmacists or pharmacies are allowed to bill as providers (mass immunizers) for the administration of certain immunizations (e.g., influenza, pneumococcal, and hepatitis B). The other exception is the supply of durable medical equipment. With durable medical equipment, pharmacies are considered as suppliers, and after approval of an application (similar to immunizations) a durable medical equipment number is granted to the pharmacy. 21, 22 Unfortunately, these bills were not acted on and will need to be reintroduced to be considered.
Although not specific to Medicare, there is a third initiative regarding pharmacist compensation. The newly passed Health Insurance Portability and Accountability Act (HIPAA) regulations include information on electronic submission of claims for pharmacist services. The X12 Pharmacy Advisory Panel was formed as a result of the new HIPAA regulations and is responsible for overseeing pharmacy-related X12 billing concerns. 23, 24 This may lead to additional strategies for pharmacist compensation. Most recently, the Prescription Drug and Medicare Improvement Act of 2003 25 was passed, which includes a brief discussion of drug therapy management programs by pharmacists. Although it is not currently known how compensation for these services will be implemented, the inclusion of them into the Medicare Improvement Act is encouraging. 7 The programs in Washington and Wisconsin more closely resemble the traditional pharmacy benefit programs, that is, reimbursement for drugs and drug product dispensing services.
Third-Party Payers
There is little published information describing payment to pharmacies or pharmacists for cognitive services provided to patients with private insurance. Some examples are available of insurance payers offering payments for specific disease-or case management-related cognitive services by pharmacists. For example, Blue Cross and Blue Shield of Tennessee developed a credentialing process for pharmacists to provide diabetes and asthma education to selected patients. 27 Once credentialed, the pharmacist is considered a provider in this network and would be paid for cognitive services for group or individual patient education. The reimbursement rates are similar to those of the Medicare, American Diabetes Association-recognized, diabetes self-management training program. 27 Some pharmacists have developed clinical relationships with MCOs for services that range from wellness and disease prevention education to disease management. Frequently, a type of capitation payment arrangement is preferred by the MCO. Capitation arrangements can be developed with companies or corporations for these same services. For example, a pharmacist could contract with an MCO or corporation to provide certain cognitive services to the employees of the organization. The pharmacist could be paid for each individual participant (at a prearranged rate), or services could be offered to all members of the organization (at a prearranged rate for the total number of employees of which any could take advantage of the program). Either of these arrangements would result in a per member per month revenue stream. There appears to be an opportunity for cognitive care in these environments, particularly with corporations that may self-insure.
Credentialing
To become a provider with a specific insurance carrier, each health care professional must become credentialed. Credentialing is the process by which the insurance company approves a specific health care professional to be a provider for their clients and thus receive compensation for providing these services. In many cases, providers such as physicians and others, including pharmacists, must be members of the insurance carrier's provider network. If the provider is not a network member, then coverage may be declined or, at the very least, the patient will pay an additional out-of-network fee. Each insurance company may have specific requirements for each type of health care professional for the credentialing process, such as specific certification or training. 28 The initial approach to the insurance carrier usually is done through the provider or medical credentialing office of that carrier. Discussing examples of services to be provided is important so that the insurance representative has a clear understanding that the pharmacist is seeking credentialing on the medical benefits side of the company and not for prescription benefits. Typically, the initial insurance representative may not be aware of pharmacists providing such services and may not know if there is a credentialing mechanism available for pharmacists. If the insurance carrier does not have a credentialing mechanism established, they may request additional background information, such as education and training, collaborative care agreements within the state, and literature regarding effects of collaborative care on patient outcomes and health care costs, to assist with the credentialing process. It may be useful to have an information sheet already prepared that outlines this information. 28 This can be faxed to the credentialing department and can assist the carrier in learning more about pharmacists as patient care providers.
In addition to the insurance carrier having requirements for credentialing, each state may have requirements that must be met. Many states have collaborative practice agreements and may require certification, specific degrees or training, and/or continuing education requirements before allowing a pharmacist to participate in collaborative care agreements. An example of this is the clinical pharmacist practitioner status for pharmacists in North Carolina in which the pharmacist, on meeting certain qualifications, can be approved by the North Carolina Board of Pharmacy and the Medical Board as a clinical pharmacist practitioner. After receiving this approval, the pharmacist is assigned an identification number from the North Carolina Medical Board. 29 Certain advanced training or certification programs may offer distinctive compensation strategies, such as becoming a certified diabetes educator or certified smoking cessation counselor. The compensation strategies used by pharmacists with some of these certification programs may be specific to that training or certification and may be independent of the actual degree held. A separate credentialing process may be required to become a provider for specific services such as immunizations and point-of-care laboratory services.
Once pharmacists, or other professionals, are credentialed, they receive a provider identification number (PIN) that they use to identify themselves on the billing claims form. This PIN may be a different number for each insurance company. One advantage for becoming credentialed with the insurance company is that as a provider, the pharmacist can submit claims to the carrier for any patient that has that insurance. Another advantage for becoming a provider with a specific insurance carrier is that it may remove restrictions in compensation strategies.
Another manner in which pharmacists might become recognized as a provider by an MCO is through an independently negotiated contract with a local payer. Generally, the services covered by these contracts are made between a network of specially trained pharmacists and selfinsured local employers or local MCOs. Examples of these types of services include the Asheville project in North Carolina, Outcomes Encounter Program (OEP) by Outcomes Pharmaceutical Health Care (OPHC) of Des Moines, Iowa, the collaborative care demonstration project in Tennessee, and services provided to Heartland HMO Medicaid patients by the University of Oklahoma College of Pharmacy.
The Asheville project is a collaboration between the North Carolina Center for Pharmaceutical Care and the City of Asheville that self-funds its health insurance plan for municipal employees, their families, and retirees. 30 In this project, specially trained pharmacists are paired with patients. Patients visit the pharmacies monthly, the pharmacists provide pharmaceutical care, document the interaction, and submit claims for services provided. The contract follows a fee-for-service format, with varying levels of intervention allowed. The average monthly fee for a 20-minute visit is about $40.
30
The OEP is a program offered by a network of community pharmacists in Des Moines, Iowa, doing business as OPHC. 30 The primary market for this network of specially trained pharmacists is, once again, self-insured employers. Employers pay a monthly fee to OPHC for OEP services to their employees, intended to decrease cost and improve quality of prescription drug benefits. Individual network pharmacists provide the services, document the service, and submit claim forms electronically to OPHC. This organization pays the pharmacists on a fee-for-service basis and provides reports to employers that summarize the number and nature of interventions with their participants, including an estimate of cost avoidance by the interventions. Fees for services vary from $7 for counseling on a new prescription to $15 for consulting with a physician about making a change in a prescription. 30 Recently, a clinical project was completed in Tennessee where a network of community pharmacists in 20 pharmacies across the state provided diabetes care (case management and education) to patients through physician referral. 31 The patient's private insurance company was billed for the service, and collection results were recorded. Another outcome measure was the determination of the clinical effectiveness of the clinical care provided by the pharmacist. Preliminary results showed that PHARMACIST COMPENSATION FOR COGNITIVE SERVICES Snella et al payment from private insurance payers occurred at approximately a 20% rate and that clinical improvement was seen in all monitored patient parameters. 31 The low insurance collection rate resulted, in large part, from the study design, which consisted of "test billing" without first establishing a provider relationship with the insurance carrier. Therefore, this approach is not recommended, although a great deal of process information was acquired during the project. In this study, most of the insurance carriers denied payment because the pharmacist was not in their "provider network." However, a similar process initiated in a physician' s office resulted in an 80% collection rate for cognitive services. 31 Several states have made an MCO within their Medicaid programs. The University of Oklahoma College of Pharmacy and Heartland Health Plan of Oklahoma is an example of a contract between a network of specially trained pharmacists, in this case established and maintained by the College of Pharmacy, and a local MCO. This MCO pays the individual network provider directly for patient care services on submission of a simple invoice for services provided. Covered services include education and self-management training in diabetes, anticoagulation, and asthma. Pharmacists are paid for one visit/patient/month, with separate fees for initial and follow-up visits.
First-Party Payers
Despite the prevalence of third-party payers, in 1998 out-of-pocket spending for health care totaled $199.5 billion, or approximately 17% of total health care expenditures. 32 Therefore, cashpaying patients, or first-party payers, can be targeted as potential sources of compensation. In fact, cash-pay situations are the most likely to ensure payment. Several pharmacists have shaped their pharmacy programs to serve this group.
Pharmacists in Washington have obtained compensation from patients for immunization programs and emergency contraception services. 30 Other pharmacists in Indiana have provided patient-focused counseling services to specifically serve cash-paying patients. 30 The investigators of Project ImPACT (Improve Persistence And Compliance with Therapy), a community pharmacy-based dyslipidemia study to improve patient adherence, reported that 75% of patients paid an average of $35/visit. 2 In contrast, 53% of third-party payers billed for services paid an average of $30/visit. Furthermore, a survey of community pharmacists in Georgia found that 100% of claims submitted to patients were paid, but only 35% of claims submitted to third-party payers were paid. 33 Evidence from these studies indicates that patients are willing to pay for services.
Pharmacists who work closely with this market suggest that pharmacists offer services that consumers expect and are willing to pay for out of pocket, choose services for which patient demand is high and for which pharmacists can fill an unmet need, carefully set fees and provide patient-friendly payment options, and are clear and straightforward regarding pricing policies. 30 
Development of Fee Structure
In the absence of any outside contracts with MCOs, all payers for a service must be charged the same fee. This means that cash-paying customers must be charged the same fee that is billed to third-party payers. To charge the insurance companies a rate higher than the cashpaying customer may be considered fraud. 34 It is important, therefore, to ensure that the fee structure is well defined and designed to cover direct and indirect costs associated with providing clinical services.
Fee structures may be developed that set the fees based on the type of service provided. Initial visits may be billed at one rate, follow-up visits at another rate. These rates might be determined on the time spent in each type of visit and at a set amount/minute (e.g., $1/min). Alternatively, the fees may be determined by the type of visit, for example, $30 for an education or consultation visit, or $35 for a bone density screening. Several examples can be found in the literature of fees charged for clinical services in community pharmacies; sample fees for a fasting lipid profile plus glucose test in community pharmacy screening programs have ranged from $25-30 in a fee-for-service structure to $300/year in a capitation program. [34] [35] [36] National Medicare reimbursement schedules are published annually in the Federal Register and may be helpful in determining a fee schedule. 37 Some providers use a capitation fee structure in which the patient might enroll in a service for a predetermined fee in exchange for a bundled package of services provided for a given period of time, such as enrolling in a lipid program for 12 months, which entitles the patient to monthly counseling sessions and five lipid profiles for a one-time fee of $300.
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Clinical services that involve laboratory services and interpretation of laboratory results may incur higher start-up costs than those of other clinical services owing to the costs involved in purchasing the instruments and laboratory kits. One author 35 described a method for calculating costs in providing lipid management services, and another 7 described the process of determining costs and setting fees.
Although providers may bill any fee they desire, if this fee is higher than the usual and customary charge typically paid by the health plan, the health plan will compensate at the usual rate paid to other providers of the same service.
This schedule is based on a formula that calculates a fee by using various determinants 38 :
where RVU is resource-based relative value unit, which is an adjusted figure to account for work provided, practice expense, malpractice expense, and geographic location, and these values are specific to Current Procedural Terminology (CPT) codes; GPCI is a geographic adjustment factor, termed Geographic Practice Cost Indices, that allows for different costs of practice in various parts of the country (e.g., the GPCI is greater in New York City than in Little Rock, Arkansas); CF is a conversion factor determined by CMS each year; and 80% is the percentage Medicare will pay toward the amount billed.
Thus, fees for various services are based on factors such as physician specialty, geographic location of the practice, determination of a relative value unit for the practice, the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code, and the particular CPT code for the patient service. 38 Most insurance companies use either the Medicare formula for payment, a modification of the Medicare formula, or a similar formula of their own. Reference tables for these factors are provided by CMS; however, these values and the current Medicare (and other pertinent third-party payer) schedules may be available though the institution's computerized billing office.
The Physical Process of Billing
Once a fee structure has been designed, proper submission of insurance claims can help increase the rate of successful compensation. There are three main strategies for billing: becoming credentialed as a provider, obtaining preauthorization before submission, and submitting the claim without prior authorization. If a pharmacist is credentialed with the insurance carrier, he or she is already authorized to submit claims to the insurance company for those patients using the pharmacist' s program. If the pharmacist is not a provider for the specific insurance company, the carrier can be contacted for preauthorization. With preauthorization, the insurance carrier preapproves compensation for the pharmacist's services on a case-by-case basis. At this time, the pharmacist can clarify if there are restrictions in billing, such as the level of reimbursement requested. The pharmacist also can submit the claim without prior authorization to see if it is approved by the company. This is sometimes known as "test billing," and if the company readily approves the claim without prior authorization, other claims to that company frequently are handled in the same manner. Even if billing is not submitted to the insurance company and payment is requested from the patient directly, it will be important to create a written invoice or billing form for the patient. This document and the register receipt can then be used by the patient as documentation of services received and paid for, and may be submitted to their insurance company for reimbursement.
Billing of Third-Party Payers
Billable services for pharmaceutical care can include, but are not limited to, drug therapy evaluations, patient education, health promotion and disease prevention activities, disease state management services, nonprescription pharmacotherapy consultations, and specialized pharmacy services. 39 Regardless of the specific service offered, the major components needed to complete the process of obtaining compensation are to obtain a provider number (as described earlier), acquire a statement of medical need and proper claim forms, write a cover letter, and prepare to submit claims to third-party payers (Figure 1) . 30, 40 A statement of medical need is a document indicating that a service provided by the pharmacist is a necessary part of the patient's treatment. Although this statement may not be required by all third-party payers, providing this statement may increase the likelihood of payment since it communicates that the patient's health care provider thought the service was necessary. This document is filled out by the patient' s health care provider to specify the service(s) requested and to give the projected duration for cognitive services; it should be signed by the health care provider. Many pharmacists have developed medical necessity forms that make it easy for health care providers to request pharmacy services by providing checkboxes, fill in the blank, or circle options that specifically name the offered services. One key component to the statement of medical need is the inclusion of a diagnostic code. The ICD-9-CM codes consist of numeric and alphanumeric codes that describe the patient's diagnosis. These codes include standard ICD-9-CM codes and V codes that describe the patient' s health condition. 19, 28 Since it is not within the pharmacist' s scope of practice to diagnose, the ICD-9-CM codes must be obtained from the referring provider. In addition, when the code from the physician matches the code provided by the pharmacist, the success rate of receiving reimbursement is higher. It is preferable to obtain the statement of medical need from the health care provider before providing a cognitive service, but the statement can be acquired after the service is performed if the health care provider decides the activity was a necessary part of care.
The next step in the compensation process is to gather the appropriate claim forms and other necessary codes. Currently, two forms are commonly used for billing of pharmacy services: the CMS-1500 and the Pharmacist Care Claim Form (PCCF). The CMS-1500 form was developed to meet the needs of many health insurers and is the most common form used for outpatient medical services. This is the required form for Medicare billing but is recognized by most third-party payers. This form consists of 33 fields to collect information about the patient, the type of service performed, the underlying condition necessitating the service, and the provider requesting compensation for the service. 7 A PIN is required in block 33 on each claim submitted to Medicare. This number is the PIN of the physician when billing is incident to physician services. It may be the PIN for the pharmacist if the third-party payer assigns pharmacists their own separate PIN. Although there are several approaches to obtaining a PIN, perhaps the most direct and successful way is to call the payer, before the claim is submitted, to determine whether that payer will issue PINs for pharmacists. If the identification number field is left blank, the payer most likely will return the claim with instructions on how to complete that field appropriately or how to obtain a PIN. 40 The unique PIN (UPIN) is slightly different and is given to physicians who are allowed to refer patients to other providers. The UPIN of the referring physician goes in 17a on the CMS-1500 form. The CMS-1500 form, as well as other CMS forms such as provider applications, can be located at the CMS Web site (www.cms.gov/forms).
Another set of commonly used codes are the CPT codes, which are used for describing medical, surgical, and diagnostic services. 18 Most pharmacy services will be reported with a CPT evaluation and management code. In the outpatient setting, this coding enables the provider to choose from a variety of codes based on seeing a new or established patient and the level of service provided. A selected list of CPT codes is shown in has strict regulations regarding services provided by nonphysicians. One of these stipulations is that for a physician to bill for a nonphysician's care (e.g., pharmacist), the nonphysician' s care must satisfy the following four eligibility requirements listed in the "incident to physician services" regulations. 41 The nonphysician' s care must be:
• "an integral, although incidental, part of the physician' s professional service; • commonly rendered without charge or included in the physician' s bill; • of a type that is commonly furnished in a physician' s office or a clinic; • furnished by the physician or by auxiliary personnel under the physician's direct supervision." These regulations were designed specifically by CMS for use in a physician's office because the regulations require that the physician be in the same suite as the nonphysician; they have limited applicability to pharmacists working in the community. Medicare also has restrictions when using "incident-to" billing in that this strategy applies only to patients who are established, meaning not a new patient to the physician, and that only the lowest CPT code can be used (99211). An important caveat with incident-to billing is that the physician is requesting compensation for pharmacists' services, not the pharmacists themselves. Another caveat is that this strategy can be used only in a physician's office, not in a hospital-based outpatient clinic. 41 Despite these requirements, this is one of few methods available to bill Medicare for services provided by a pharmacist. Other insurance carriers may allow billing for new patients (vs established) and for use of other CPT codes.
(Compensation strategies for a hospital-based 380 Preventive medicine counseling and/or risk factor reduction intervention(s) None specified 60
Time is defined as duration of face-to-face time with the patient and/or family. When counseling and/or coordination of care takes up more than 50% of the encounter, then time may be considered the key controlling factor to qualify for a particular level of services.
clinic are specific to that environment. A review of these strategies is provided elsewhere.) 42 The three components used to determine the level of service provided (e.g., CPT code) are extent of history obtained, extent of examination performed, and complexity of medical decision making. 18 Although time is not often used as a marker of selection for a CPT code, it may be used as an alternative for the total work involved in providing the service. It is important to note that the documentation for the service must support the code choice(s). 43 In most instances, outpatient or community pharmacists would not bill higher than a third-level code (i.e., 99213). It is acceptable to submit multiple CPT codes when more than one service is provided. For example, if a pharmacist performs a laboratory test, immunization, and patient education for one patient, several codes may be submitted to the third-party payer to describe each service.
The second claim form is the PCCF, which was developed by the National Community Pharmacists Association (formerly the National Association of Retail Druggists). The various sections of the form contain patient information, coding for activities, free text for discussion, certifications, and pharmacy information. The PCCF is primarily based on the National Council for Prescription Drug Programs Professional Pharmacy Services codes. These codes are not specific to a particular service but describe the basic framework for patient care activities. Since most insurers are not familiar with this form, PCCF can be submitted with the CMS-1500.
When the appropriate forms have been completed, the pharmacist should prepare a cover letter to send to the third-party payer. This letter should include a statement of purpose (request for payment of professional services), the patient' s name and identification number, the date and location of service, anticipated outcomes, and the list of documents enclosed with the letter. These documents would include the statement of medical necessity, the CMS-1500 form, the PCCF, and documentation of the service. This letter "sets the stage" for the remaining enclosures; therefore, it should be succinct, clear, and express justification for compensation.
Finally, the claim can be submitted to the third-party payer by hard copy or electronically. Hard-copy submissions are most useful for firsttime submissions and should include all components listed above. Once a relationship is established between the pharmacist and the company, electronic submissions may be easier, provide faster payment for services, and may require only submission of the CMS-1500. In addition, electronic submissions often are used for mass immunizations.
Payment for claims usually will take 4-6 weeks. The pharmacist or the billing department should follow up on claims that have not been paid after 8 weeks. 40 If a claim has been rejected or denied, the responsible personnel should call the billing department of medical benefits for the third-party payer and request an explanation. The reasons for rejection will vary. It simply may be not completing the claim form properly or providing insufficient documentation. Regardless of the explanation, the pharmacist should make any needed changes and resubmit the claim. If the third-party payer does not compensate pharmacists, then decision makers in the company should be contacted to explain the value of the services and be given a valid rationale for changing the policy. The key to receiving compensation is perseverance. Pharmacists may have to resubmit a claim several times before it is paid, but once the payer accepts the claim, compensation in the future is likely to occur in a more timely fashion. If the claim con-tinues to be rejected after exploring all potential options with the third-party payer, the pharmacist can seek compensation from the patient.
If claims are rejected, clarify the reason for rejection, correct the error or oversight, and resubmit. Errors in claim submission, such as missing information, may be a reason why a claim is denied. Claims may also be rejected because of lack of supporting documentation. 44 Contacting the insurance company when claims are rejected and making corrections can help decrease the risk of denial when submitting future claims to the insurance company. The process of billing, from gathering forms to resubmitting claims, can be time-consuming. Computerized records and using support personal such as pharmacy technicians and other support staff can be invaluable. Example statements of medical need, the CMS-1500 form, and the PCCF have been published. 7, 34 
Documentation in the Medical Record
Copies of the items submitted to the insurance company and a copy of the patient's insurance card should be kept in the medical record. In addition, the patient visit should be documented adequately in the medical record. In the physician office, a medical record or chart for the patient may exist. In the community pharmacy, a PHARMACOTHERAPY Volume 24, Number 3, 2004 method of documentation may need to be developed. The method of documentation may be written or electronic. Regardless of the setting, different formats are used for documenting patient care visits, such as the subjective, objective, assessment, and plan note method or the subjective, objective, assessment, plan, implementation, and evaluation method. In general, the level of documentation required increases depending on the complexity and type of visit. The basic elements that must be documented are history, physical examination, and complexity of decision making. The 1997 Documentation Guidelines for Evaluation and Management Services describes what physically needs to be documented in the chart to support the appropriate CPT code. 43 This becomes paramount to follow when documenting visits for Medicare patients, as it is this record that will be reviewed to support billing practices during an audit. For example, when documenting for the CPT levels 99211-99215, the chief complaint must be documented and two of the three elements (history, physical examination, and complexity of decision making) must be at a level high enough to support the CPT code selected. 43 The higher the CPT code selected, the more detailed documentation is required (99215 vs 99212). With the CPT code 99211, no official documen-tation is required by CMS regarding history, physical examination, and complexity of decision making; however, it is prudent to provide documentation of the visit and documentation of physician supervision in the medical record. With CMS, billing the higher CPT codes requires that there be clear documentation that the physician had face-to-face contact with the patient and which portions of the interview and examination were performed by that individual.
Clinical Laboratory Improvement Amendments Billing
All laboratory testing performed on humans with the exception of that conducted for research is regulated by the CMS as designated by the Clinical Laboratory Improvement Amendments (CLIA) of 1988. The CLIA require every "facility that tests human specimens for the purpose of providing information for the diagnosis, prevention, or treatment of disease or impairment of, or the assessment" of health to meet certain federal requirements. 45 If a pharmacy wishes to provide tests such as hemoglobin A 1c or fasting lipid profiles, it is considered a laboratory and must possess a CLIA certificate. Application materials may be downloaded as a Portable Document Format, or PDF, file from the CLIA Web site or may be requested by mail from the CLIA state survey agency. 35, 46, 47 Materials provided include the application form, instructions for completion, commonly performed waived tests, and associated CPT codes.
Additional regulations exist in many states for CLIA-waived testing; therefore, individual state agencies should be consulted for information concerning their requirements. Completed applications should be mailed to the appropriate state agency and will be processed within 30 days. Once obtained, the CLIA waiver must be displayed in the laboratory site designated as the home base. 35 All reagents, test cassettes, and logbooks must be kept in this site and are subject to inspection. Owing to a new initiative, 2% of CLIA-waived laboratories are subject to annual inspection. 17 Other inspections may be held to investigate complaints or to verify that only waived tests are being performed. In addition to the CLIA-specific regulations, there may be additional state or federal regulations that need to be followed, such as the Occupational Safety and Health Administration regulations.
Although little has been published concerning pharmacists billing using a CLIA waiver, a PIN can be assigned based on their CLIA number. The list of recognized provider or supplier types found at the CMS Web site includes Independent Clinical Laboratory (CLIA). 48 The CLIA laboratories are directed to contact their Medicare carrier for a CMS-855B enrollment application. An imbedded hot link provides needed contact information for these carriers or can be downloaded on the CMS Web page (www.cms.gov/forms/). Any questions concerning completion of the application are directed to the Medicare carrier. A hard copy of the completed form must be mailed to the Medicare carrier. At the same time, the state agencies must be contacted for any additional forms and required information. Some state agencies will provide assistance in Medicaid enrollment. Once the carrier has accepted the application and received proof of the CLIA certificate, billings for laboratory services will be permitted.
Billing as Mass Immunizer
Unlike the previous example in which the pharmacy receives the PIN, when billing as a mass immunizer, either the pharmacy or the PHARMACIST COMPENSATION FOR COGNITIVE SERVICES Snella et al pharmacist may receive the PIN. To receive a PIN, the pharmacist or pharmacy may submit an application to CMS (form 855). When approved, the pharmacist or pharmacy may bill their 383 Figure 2 . Example of influenza mass immunization claim form using the CMS-1500 form. Place the following information in the box indicated: box 2, "see attached roster"; box 11, "none"; box 17, name of the protocol physician; box 17a, protocol physician' s provider identification number (PIN); box 21.1, code "v04.8"; and box 24B, "99" for place of service. Box 25, tax identification number, must be completed. In Box 27, mark "yes" to accept assignment. Complete address information in box 33 and include the PIN assigned to the mass immunizer. Mail a hard copy or submit electronically.
Medicare intermediary for administration of these vaccines. The state boards of pharmacy also regulate administration of immunizations and may have additional regulations before the pharmacist may begin providing these services.
Multiple immunization programs documenting success in receiving compensation for these services have been described in the literature. One group of authors described a successful immunization program implemented in community pharmacies in Virginia. 49 In this report, the pharmacies were granted the PINs. Another author described a program in which individual pharmacists were recognized as mass immunizers. 35 Both programs reported successful submission and payment for claims to Medicare, as well as cash payments from non-Medicare patients.
The CMS directs inquiries about this provider status to the regional Medicare carrier who will provide information concerning the application and any additional required documentation. 50 Once the PIN as a mass immunizer is obtained, roster billing must be used to submit claims. In this scenario, a roster is kept of all patients receiving the immunizations on a given date. This roster must include the patient's Medicare identification number, complete name, address, sex, date of birth, date of service, and patient signature. One claim form is used for each date of service and is submitted with the roster(s) for that date. This submission may be accomplished by sending a hard copy through the mail or by electronic medical claim submission. The reader is referred to the sample claim form provided in Figure 2 , which indicates the fields to be completed on the CMS-1500 form for an influenza mass immunization service.
Application to the Community Pharmacy and Office Setting
To clearly illustrate the different nuances between compensation within the community pharmacy and the physician office environment, it is easiest to use one patient scenario and then discuss the differences that might occur in each setting. One disclaimer is that all patient care environments will have distinct situations and that not all compensation strategies will be the same in each setting. For example, a pharmacy located in a physician office may be able to adapt compensation strategies that are used in the physician office, especially if the pharmacist can physically see patients in the physician suite and meets all the incident-to-physician services criteria.
The Scenario
The patient is a 70-year-old woman with a written referral from her primary care physician for a cardiovascular risk reduction assessment and counseling. She has a medical history of coronary artery disease, hypertension, and obesity. Her daily drug regimen includes a diuretic, ␤-blocker, angiotensin-converting enzyme inhibitor, and aspirin. She has sublingual nitroglycerin available if needed. Her social history includes smoking one half pack/day; she denies alcohol and illicit drug intake. She received the pneumococcal vaccine and most recent tetanus booster at age 67 years. Her last visit to her physician was 12 months ago. Medicare serves as her primary insurance carrier, and she also has supplemental insurance.
Community Pharmacy
The patient presents her request for services to the pharmacist who is staffing a regularly scheduled cardiovascular risk reduction service in the community pharmacy. As part of the service, the patient's blood pressure and fasting lipid profile are checked. Lipid goals and cardiovascular risk reduction strategies are discussed, including smoking cessation, diet, and lifestyle changes. The patient is advised to receive an annual influenza immunization.
The patient agrees to attempt the lifestyle changes for 3 months and asks if she may have her fasting lipid profile checked again at that time. The pharmacist schedules an appointment for 3 months from today' s date for the follow-up fasting lipid profile and explains that since CMS will cover only one fasting lipid profile/year, the patient will be expected to pay for the next cholesterol test. The pharmacist advises the patient that if she returns to the pharmacy next week during the annual flu shot clinic, the pharmacist will be able to bill Medicare for the flu shot.
The pharmacist provides a brochure explaining the details of the smoking cessation program offered by the pharmacy. Smoking cessation services at this pharmacy are offered as a cashbased service only, and the pharmacy offers several options for payment of the charges, including monthly cash payments or credit cards. The patient agrees to consider enrolling in the next smoking cessation class, scheduled to begin next month. The patient signs a statement that she will be responsible for today' s bill if the claim is rejected by CMS and leaves for the day. The pharmacist completes the documentation of the visit and files it in the pharmacy' s clinical patient files, along with a copy of the physician' s referral.
Since this is a small community pharmacy and support staff is limited, the billing for the visit to the cardiovascular risk reduction service is completed by the pharmacist staffing the service. The pharmacist contacts the physician' s office to obtain the patient's exact ICD-9-CM diagnosis codes. Since the pharmacist has a CLIA waiver and the pharmacy has been recognized by CMS as an independent laboratory, the pharmacist can submit a claim to CMS for the laboratory services offered today. The PIN used is based on the CLIA number. The CMS-1500 form is completed by using the CPT code 80061QW for the lipid profile and the diagnosis codes as provided by the physician. A copy of the referral letter and documentation of the visit are sent with the completed form.
The patient returns to the pharmacy the next week and is one of 25 patients receiving their annual influenza vaccine. The pharmacist coordinating this flu shot service has obtained a mass immunizer PIN from CMS and uses roster billing to submit claims. The pharmacist has experienced the most success billing under this scenario if the roster contains at least six names, so she has scheduled appointments and advertised the clinic widely to help ensure a sufficient number of patients will come to the clinic to support roster billing. One month later, the scenario patient enrolls in the smoking cessation program. She pays for the entire program at the initial class meeting by charging it to her credit card.
In addition to cash payments for cognitive services, community pharmacists also may submit bills to private third-party payers. There is the possibility that services for new and/or established patients may be compensated at a higher CPT code than 99211. In addition, codes for preventive medicine counseling and risk factor reduction intervention 99401-99404 may be useful to community pharmacists when contracting with private insurance companies and MCOs. The pharmacist should pursue this with the insurance company and seek assistance from a case manager in major medical coverage. Because pharmacists practicing in a community pharmacy typically do not meet all the criteria in the incident-to regulations, this compensation strategy (by CPT code 99211) is usually not available.
When submitting claims for specific laboratory tests, the frequency of testing may be limited by the patient's insurance carrier to a certain number/year (i.e., one fasting lipid profile/12-mo period). If a patient is a self-referral for cholesterol screening and wants the pharmacist to submit a claim to the insurance carrier for the laboratory services, provisions should be made to submit the bill directly to the patient if the claim is rejected by the insurance carrier.
Physician Office
If the previously described scenario were to occur in a physician office, there would be little difference in the types of education provided. Her care plan would still include a cardiovascular risk reduction assessment and counseling (including having her blood pressure and fasting lipid profile measured); educating her about strategies to control her high blood pressure and cholesterol and to stop smoking; and offering her an influenza vaccination. As part of the hyperlipidemia education, strategies for exercise, diet, and weight loss are also discussed.
Most differences would occur in the areas of immunizations, laboratory tests, referrals, and billing and submitting claims. If an influenza vaccine is offered to the patient, the pharmacist need not be a mass immunizer to bill the insurance carrier. The billing for this vaccine will be done in the same manner as when a nurse administers the vaccine. In terms of laboratory services, the tests may be done with use of existing laboratory services (most clinics have inhouse laboratory service), a point-of-service machine, or a combination of the two. Since expanded laboratory services may be accessible, the pharmacist will have greater ability to monitor the patient in terms of ordering laboratory tests (e.g., if liver function tests or creatine kinase evaluations are needed) since they are not restricted to using only CLIA-waived machines.
If the patient was referred to the pharmacist from one of the physicians practicing within the clinic, the referral usually is included in the medical chart (if from an internal physician) or a separate referral may be received if from a practitioner outside the clinic. If an external physician is referring the patient and the patient has a third-party insurer, the insurance company may need to be contacted for prior authorization. In this case, it will be a referral to whoever is considered the supervising physician if the pharmacist is using the incident-to regulations or to the pharmacist if he or she has provider status with the insurance carrier. Medicare and Medicaid patients do not require prior authorization to be seen.
As mentioned previously, most pharmacists in this patient setting use the incident-to regulations, and a supervising physician will bill for the pharmacist's services. The CPT code 99211 will be used to code for services rendered. Some pharmacists have successfully become providers with third-party payers and are able to bill at higher CPT levels. Regardless of the CPT code selected, the fee structure is usually already developed by the clinic (e.g., there are uniform fees for each CPT code). Because this patient has been seen in the last 12 months (assuming an internal referral), she will be billed as an established patient. However, the incident-to regulations restrict billing for nonphysicians to established patients only.
Fortunately, most physician clinics have personnel dedicated to managing claim submissions to the various insurance carriers. Claims typically are submitted electronically, and if denied, these personnel usually are the ones to contact the insurance carrier to find out the reason for the denial. In this scenario (assuming incident-to regulations), the carrier would be billed for a 99211 visit with the ICD-9-CM codes of 414.01 (native coronary artery disease), 401.1 (essential hypertension), and 305.1 (tobacco use). 19 If the laboratory department performed the fasting lipid panel, the laboratory would submit the charges.
Conclusion
Although the provision of cognitive services has changed dramatically in the past decade, parallel advances have not been made in billing for pharmacist cognitive services to third-party payers. Pharmacists have been resistant to file claims to insurance companies because of time constraints, lack of confidence in receiving payment, fear of change and patient perceptions, potential creation of "turf wars" with other health care providers, and various other reasons. 51 But to provide the pharmaceutical services that have proved to benefit health care outcomes in a profitable manner, pharmacists must be willing to do what other health care professionals do to secure compensation for their services. These activities include developing a relationship with the first-or third-party payer, becoming credentialed, creating a fee structure, learning the physical process of billing, and obtaining appropriate waivers and/or approvals to provide specific pharmacy services. With successful compensation for services, pharmacists can continue to provide quality patient care and be recognized as providers of direct patient care by insurance carriers.
